Myopia Management Market By Treatment Type (Atropine Eye Drops, Prescription Lenses {Single, Bifocal, Trifocal, Others}, Contact Lenses {Orthokeratology Lenses, Multifocal Contact Lenses}, Surgical Interventions), By Age Group (Children, Adolescents, Adults), By Distribution Channel (Hospitals & Ophthalmic Clinics, Optometry & Vision Care Centers, Retail Pharmacies, Online Platforms), By End-user (Pediatric Patients, Adults with Progressive Myopia, Others), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 – 2035

---

What trends will shape the Myopia Management Market in the coming years?

The Myopia Management Market accounted for USD 12.52 Billion in 2024 and USD 13.66 Billion in 2025 is expected to reach USD 32.6 Billion by 2035, growing at a CAGR of around 9.1% between 2025 and 2035. Myopia Management Market revolves around the products and interventions that are used in hindering and limiting the rise of myopia (nearsightedness), particularly among children and teenagers.

It contains special contact lenses, atropine eye drops, orthokeratology, and interventions that are lifestyle-based. New emerging trends are rising awareness among parents, new developments in the technology of diagnostics, and AI-based vision correction devices. Future opportunities are exploring early diagnosis and incorporation of eye health digital technologies, and the ever-increasing use of preventive care practices among eye care professionals. 

What do industry experts say about the Myopia Management Market trends?

"Orthokeratology and multifocal soft contact lenses are game-changers in myopia control. Clinicians must move beyond simple refractive correction and adopt these therapies as standard care."

• Dr. James Wolffsohn, Optometry Academic & Researcher

Which segments and geographies does the report analyze?

What are the key drivers and challenges shaping the Myopia Management Market?

Is rising screen time accelerating childhood myopia progression worldwide?

The Myopia Management Market is highly fueled by the fact that children are getting exposed to digital screens at high rates, such as smartphones, tablets, and computers. Due to school activities moving towards online classes, computer entertainment, and less time in natural light, children are spending more time than normal inside with little exposure to natural light. Such a habit has been associated with the early development and the more rapid development of myopia. East Asian, North American, and European studies indicate a direct relationship between digital screen viewing and refractive errors in school-going children. With the increase in screen usage being inevitable, especially in the post-pandemic era, myopia control measures have also shot up.

The Myopia Management Market is experiencing an increase in demand for preventive interventions such as atropine drops, organic lenses, and smart eyewear to minimize eye strain and narrow axial elongation. The need to act immediately has been demonstrated by the fact that many health institutions around the globe and regions have set down guidelines on screen time among children. Visual excess is causing more market requirements because of the increasing use of educational and entertainment devices that are integrated with technology. Firms have reacted by providing vision training equipment and blue light-blocking glasses, and this increases the relevance of the product in the market.

Are parents becoming more aware of early myopia intervention needs?

The Myopia Management Market is, in turn, substantially driven by the increase in awareness of parents regarding the adverse long-term effects of progressive myopia. There is rising awareness among parents about the possible implications of poorly managed myopia, such as retinal detachment, glaucoma, as well as macular degeneration during adulthood. Healthcare professionals, non-governmental organizations, as well as eye care brands are launching awareness campaigns to educate families on the need to check their eyes early and intervene. This change of mindset is supporting parents to seek quality and safe measures to correct their children's vision and future eye wellbeing.

Early diagnosis of the disease is also becoming frequent as access to optometrists as well as pediatric ophthalmologists in the urban areas is improved. This proactive eye care is contributing to the growth of the Myopia Management Market, especially in those nations that have a large population of children and an accelerated pace of digitalization. Timely parent-driven decisions are also coming as a result of increased influence and influence of health awareness platforms in social media. Annual screening of children for vision is recommended as one of the standard procedures in educational institutions and by pediatricians. This expanding world of early detection is creating long-term customer engagement among the industry players.

Are high treatment costs limiting access in low-income urban areas?

The affordability factor has been a major limiting factor in the Myopia Management Market, despite creating more awareness amongst the population, particularly in developing countries and underprivileged urban populations. Treatment of myopia that involves the use of orthokeratology lenses, special spectacles, and long-term atropine is expensive. A good percentage of these treatments are not covered by either the public or the private insurance schemes, which becomes a burden on the middle to the low-level income families. Moreover, the follow-ups and eye tests contribute to the costs since regular check-ups are necessary. Due to this, most of the children in the lower-income bracket are either untreated or put under simple prescription glasses, which fail to gradually cause a reduction in the rate of occurrence of myopia.

This cost barrier restricts the entry of high-end solutions to the Myopia Management Market, which in turn gives rise to the gap between the demand and accessibility of the solutions, especially in the price-sensitive areas. In addition to that, rural and semi-urban locations are also not usually merchandised by trained fellow workers who conduct such advanced interventions of sorts. Informal organizations (NGO) and government programs continue to have geographic and financial scope restrictions. To expand its markets to a wider dimension, alternatives and public-private partnerships are strongly needed at affordable costs.

Will digital health tools enhance remote myopia tracking and management?

The Myopia Management Market has a great opportunity following the implementation of digital health solutions, mainly remote monitoring and personalization of treatment. The mobile applications, smart glasses, and AI-based platforms as diagnostic tools are being created to monitor the axial eye growth, screen time, and sufficiently comply with the myopia control interventions. Such solutions become particularly useful in places where regular clinical care is underrepresented. They also offer the opportunity for cooperation among the parents and the doctors, so that they can keep track of them more effectively.

The introduction of telehealth platforms is enabling prompt communications, dose modification, and patient adherence to treatment. With the heightened rate of digital applications in both developed and developing markets, the innovations are likely to increase the Myopia Management Market substantially through greater scalability, data-backed, and access to care. Implementing a digital comprehensive prevention & control strategy reduced myopia rates to ~86–88% in 18-year-olds and significantly decreased high‑myopia by 1–2 percentage points, and was deemed cost-effective.  Population-scale screening is also becoming possible in the school and community health environment through the use of such tools.

Can wearable devices support behavioral change in young myopic patients?

Wearable devices are also proving to be an upcoming opportunity in the Myopia Management Market that will work towards altering environmental and behavioral risk factors. Such technologies as smart posture trackers, ambient light sensors, and myopia-specific eyewear can assist in watching over and enhancing the visual routine of children. Such devices can remind them of bad lighting environments, too much near work, or the wrong viewing distances, and motivate them into healthier behaviors to further the slowing of myopia progression. They are particularly convenient when used by children due to the flexibility in learning via their ability to meet and uphold engagement rates through integration with gamified mobile apps.

The adoption of such innovative tools is picking up pace as people become more aware of preventive eye care. Not only do these accessories facilitate corrective vision, but they also engage children in the process of managing their eyes interactively, broadening the market for Myopia Management and making it more effective. Digital wellness modules, including such tools, are already becoming a part of educational programs. Initial studies on pilots indicate that the use of wearables with traditional therapies leads to a high level of improvement in compliance. The processes indicate that someday behavioral tracking may be a routine component of eye care solutions.

What are the key market segments in the Myopia Management industry?

Based on the Treatment Type, the Myopia Management Market has been classified into Atropine Eye Drops, Prescription Lenses, Contact Lenses, and Surgical Interventions. The most common ones are the Prescription Lenses-there are several prescription lenses available, such as the bifocal lens and the single-vision lens, which is the most prevalent because of ease of use, cheapness, and low accessibility.

These lenses are used widely as the initial step of intervention, particularly in the case of pediatric patients. Atropine Eye Drops are in the meantime gaining momentum as it has been proven in the clinics to be effective in slowing myopia progression. Orthokeratology and multifocal contact lenses represent the other forms of contact lenses that are on the rise among teens and adolescents who would like a non-surgical option. Surgical interventions, however, are a small area and are mainly restricted to adults with severe or stabilized myopia.

Based on the Age Group, the Myopia Management Market has been classified into Children, Adolescents, and Adults. The Children segment is the largest segment of the Myopia Management Market, since very early diagnosis and treatment are the most effective during the years of growth. The onset of myopia usually occurs in school-going children and slows down the progression at an early age. Disorder can occur much later in life.

This segment is witnessing high demand due to increased awareness of parents, school screening programs, and referrals by pediatric ophthalmologists. The Adolescents group comes next, and there is a tendency towards high usage of contact lenses and lifestyle effects. The Adult segment has a smaller contribution to the management market, since treatment is not so aimed at controlling progression, but more at correction. In this way, the high popularity of the children's part implies a very strong emphasis on prevention ability and early interception in the market.

Which regions are leading the Myopia Management Market, and why?

The Asia-Pacific Myopia Management Market makes up the largest market share because of the exceptionally high rate of myopia, especially among the children of countries such as China, Japan, South Korea, and Singapore. The biggest factors that lead to the premature development of myopia or the increase of it in this region are urbanization, academic pressure, and long-term use of screens.

Governments and health agencies are going stronger with school vision screening programs and mass publicity. Moreover, a strong healthcare establishment and the availability of leading industry players that provide state-of-the-art myopia control products favor the dominance of the market. This makes (and will keep) Asia-Pacific the leader in demand and innovation in the scenery concerning myopia management.

North America Myopia Management Market is becoming the fastest developing region, with the reasons being the growing awareness of parents and extensive use of the FDA-approved myopia management treatment, such as MiSight contact lens. Favorable reimbursement policies and the presence of a vast number of optometrists have been witnessed to emphasize pediatric vision care in the region.

Trends in digital learning and the change of lifestyle after COVID-19 have also predetermined the development of early-onset myopia, which has increased the demand for early interventions. Innovative studies, technology-enabled vision monitoring, and regulatory clearance of products with approval are fastening the industry. All these things put North America at the forefront as a very dynamic and growing area within the next few years.  

What does the competitive landscape of the Myopia Management Market look like?

The Myopia Management Market is very competitive due to innovations, strategic alliances, and the growing demand to have early intervention solutions in the market of myopia management. The vendors like EssilorLuxottica, CooperVision, Johnson & Johnson Vision, HOYA Corporation, Carl Zeiss Meditec, and Bausch + Lomb are the key drivers in the market with intensified R&D activities and international expansion. EssilorLuxottica is turning to custom spectacle lenses and the markets of the East. CooperVision is still the leader in the contact lens market through MiSight lenses (approved by the FDA in 2019) and other commitments to additional purchases of companies specializing in specialty lenses. Johnson & Johnson Vision is also providing the ortho-K lens and mobile health tracking integrated solutions.

HOYA is spreading those MiYOSMART lenses to several regions that are supported clinically. The Carl Zeiss company is working on its MyoCare lens technology to supply the European markets, whereas the Bausch + Lomb and Alcon companies are working on pharmaceutical alternatives such as the low-dose atropine. Technology firms are also focusing on investment in digital health platforms, training of practitioners, as well as clinical trials to distinguish their offerings. Comprehensively, product innovation, development in different regions (regional expansion), and holistic vision care solutions are contributing to the competitive environment to achieve the global increase in the incidence of myopia.

Myopia Management Market, Company Shares Analysis, 2024

To explore in-depth analysis in this report - Request Sample Report

Which recent mergers, acquisitions, or product launches are shaping the Myopia Management industry?

• In June 2024, the FDA approved CooperVision’s MiSight® 1 day contact lenses for myopia progression in children aged 8–12. This approval strengthens CooperVision’s leadership in pediatric eye care and expands access to clinically proven myopia management solutions.
• In February 2024, Alcon partnered with the Singapore Eye Research Institute (SERI) to advance myopia control innovations. The collaboration aims to accelerate research in novel treatments and improve early intervention strategies for pediatric myopia.

Report Coverage:

By Treatment Type

• Atropine Eye Drops
• Prescription Lenses
  • Single
  • Bifocal
  • Trifocal
  • Others
• Contact Lenses
  • Orthokeratology Lenses
  • Multifocal Contact Lenses
• Surgical Interventions

By Age Group

• Children
• Adolescents
• Adults

By Distribution Channel

• Hospitals & Ophthalmic Clinics
• Optometry & Vision Care Centers
• Retail Pharmacies
• Online Platforms

By End-user

• Pediatric Patients
• Adults with Progressive Myopia
• Others

By Region

North America

• U.S.
• Canada

Europe

• U.K.
• France
• Germany
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India
• Australia
• South Korea
• Singapore
• Rest of Asia Pacific

Latin America

• Brazil
• Argentina
• Mexico
• Rest of Latin America

Middle East & Africa

• GCC Countries
• South Africa
• Rest of Middle East & Africa

List of Companies:

• EssilorLuxottica
• CooperVision
• Johnson & Johnson Vision
• Bausch + Lomb
• HOYA Corporation
• Carl Zeiss Meditec AG
• Alcon
• Menicon Co., Ltd.
• Topcon Corporation
• Essilor Instruments
• SightGlass Vision
• SynergEyes, Inc.
• Euclid Systems Corporation
• Paragon Vision Sciences
• Nidek Co., Ltd.

Frequently Asked Questions (FAQs)